Trastuzumab: mechanisms of resistance and therapeutic opportunities.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
Works matching IS 08909091 AND DT 2008 AND VI 22 AND IP 11
Results: 31
1
2
Second opinion. A perimenopausal woman with a small, ER/HER2-positive, node-negative breast cancer.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
3
The Calabrich/Fernandes/Katz article reviewed. Trastuzumab resistance: bringing tailored therapy to the clinic.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
4
Integrative oncology: complementary therapies, herbs, and other OTC agents. Milk thistle.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
5
What is the optimal treatment of localized pancreatic adenocarcinoma?
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
6
Areas of confusion in oncology. The Duffy/O'Reilly article reviewed. Challenges on the road to treatment advances for pancreatic cancer.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
7
Areas of confusion in oncology. The Duffy/O'Reilly article reviewed. Treating localized pancreatic cancer: when and how?
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
8
Announcements.
- Published in:
- 2008
- Publication type:
- Journal Article
9
Understanding and treating triple-negative breast cancer.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
10
Severe Stress More Common Among Long-Term Cancer Survivors, Study Shows.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 11, p. 1307
- Publication type:
- Article
11
Research reports. Gefitinib superior to doublet chemotherapy in phase II Asian first-line advanced NSCLC study.
- Published in:
- 2008
- Publication type:
- Journal Article
12
More on futile care: feelings of abandonment, confusion, and wishful thinking.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
13
Complementary Therapies, Herbs, and Other OTC Agents.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 11, p. 1319
- By:
- Publication type:
- Article
14
The Anders/Carey article reviewed. Triple-receptor-negative breast cancer: what we know and issues to be resolved.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
15
Hormone Therapy Before Radiation Seed Implants for Prostate Cancer May Shorten Life for Older Patients.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 11, p. 1306
- Publication type:
- Article
16
Acupuncture Reduces Side Effects of Breast Cancer Treatment as Much as Conventional Drug Therapy.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 11, p. 1306
- Publication type:
- Article
17
Treating Localized Pancreatic Cancer: When and How?
- Published in:
- Oncology (08909091), 2008, v. 22, n. 11, p. 1296
- By:
- Publication type:
- Article
18
Challenges on the Road to Treatment Advances for Pancreatic Cancer.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 11, p. 1294
- By:
- Publication type:
- Article
19
What Is the Optimal Treatment of Localized Pancreatic Adenocarcinoma?
- Published in:
- Oncology (08909091), 2008, v. 22, n. 11, p. 1283
- By:
- Publication type:
- Article
20
Radiation Added to Hormone Therapy Increases Survival for Men With Prostate Cancer.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 11, p. 1278
- Publication type:
- Article
21
Granisetron Patch Approved for CINY.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 11, p. 1248
- Publication type:
- Article
22
Study Finds 3-Week Radiation Therapy as Effective as 5 Weeks for Early-Stage Breast Cancer.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 11, p. 1278
- Publication type:
- Article
23
Trastuzumab Resistance: Bringing Tailored Therapy to the Clinic.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 11, p. 1259
- By:
- Publication type:
- Article
24
Trastuzumab: Mechanisms of Resistance and Therapeutic Opportunities.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 11, p. 1250
- By:
- Publication type:
- Article
25
Consensus Report Urges Increased Support for the Metastatic Breast Cancer Community.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 11, p. 1248
- Publication type:
- Article
26
Pemetrexed Receives Third US Approval, as Part of First-Line Regimen for NSCLC.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 11, p. 1248
- Publication type:
- Article
27
A Perimenopausal Woman With a Small, ER/HER2-Positive, Node-Negative Breast Cancer.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 11, p. 1270
- By:
- Publication type:
- Article
28
Understanding and Treating Triple-Negative Breast Cancer.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 11, p. 1233
- By:
- Publication type:
- Article
29
Gefitinib Superior to Doublet Chemotherapy in Phase III Asian First-Line Advanced NSCLC Study.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 11, p. 1246
- Publication type:
- Article
30
More on Futile Care: Feelings of Abandonment, Confusion, and Wishful Thinking.
- Published in:
- 2008
- By:
- Publication type:
- Letter
31
Triple-Receptor-Negative Breast Cancer: What We Know and Issues to Be Resolved.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 11, p. 1239
- By:
- Publication type:
- Article